Project Number 5P01AG003991-35 Agency/Funding Organization NIA Funding Year 2018 View Full Project Details for Project 2: Sleep: Potential Prognostic and Theranostic Marker for Preclinical AD Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category B. Diagnosis, Assessment, and Disease Monitoring 3. Traditional assessments Researcher and Organization Principal Investigator HOLTZMAN, DAVID M Principal Investigator First Name DAVID Principal Investigator Last Name HOLTZMAN Awardee Organization WASHINGTON UNIVERSITY IN SAINT LOUIS Awardee State Missouri Contact PI Country United States Project Detail Funding Opportunity Announcement PAR-13-329: NIA Revision and Resubmission Program Project Applications (P01) FY Overall Cost $438,889 Funding Organization Agency/Funding Organization NIA Funding Organization Country United States Program Official HSIAO, JOHN Related Resources Repository [NIAGADS] SORL1 coding variants and risk for AD [NIAGADS] Transethnic GWAS Summary Statistics - Jun et al. (2017) [NIAGADS] CSF Summary Statistics [NIAGADS] ADGC African American Summary Statistics- Reitz et al. (2013) [NIAGADS] ADGC Neuropath Summary Stats and Phenotypes- Beecham et al. (2014) [NIAGADS] ADGC Summary Statistics- Naj et al. (2011)
